Search

Displaying results 3701 - 3710 of 7063 in total
  1. Drug

    Olive oil

    go.drugbank.com/drugs/DB09567
    ApprovedInvestigational

    Used as a source of fatty acids in total parenteral nutrition and as an additive in some cosmetic products [FDA Label].

  2. Drug

    Crobenetine

    go.drugbank.com/drugs/DB21095
    Investigational

    Crobenetine has a monoisotopic molecular weight of 379.25 Da. … Crobenetine is a small molecule drug.

  3. Drug

    Dalzanemdor

    go.drugbank.com/drugs/DB21549
    Investigational

    Dalzanemdor has a monoisotopic molecular weight of 456.32 Da. … Dalzanemdor is a small molecule drug.

  4. Drug

    Desloratadine

    go.drugbank.com/drugs/DB00967
    ApprovedInvestigational

    Desloratadine is a second generation, tricyclic antihistamine that which has a selective and peripheral H1-antagonist action. … It is the active descarboethoxy metabolite of loratidine (a second generation histamine).

    Mixtures: Clarinex-D 12 Hour, Clarinex-D 24 HourProducts: GLOBISTAMIN D, GLOBISTAMIN D JARABE
  5. Drug

    Galamustine

    go.drugbank.com/drugs/DB21062
    Experimental

    Galamustine has a monoisotopic molecular weight of 303.06 Da. … Galamustine is a small molecule drug. The usage of the INN stem '-mustine' in the name indicates that Galamustine is a antineoplastic, alkylating agent, (β-chloroethyl) amine derivative.

  6. Drug

    Brodalumab

    go.drugbank.com/drugs/DB11776
    ApprovedInvestigational

    Brodalumab was FDA approved in February, 2017 as Siliq for the treatment of moderate-to-severe plaque psoriasis.

    Categories: Interleukin-17 Receptor A Antagonist, Interleukin 17 Receptor A Antagonists
  7. Drug

    Diiodohydroxyquinoline

    go.drugbank.com/drugs/DB09115
    Approved

    Iodoquinol is not currently available in any FDA-approved products. … Diiodohydroxyquinoline, also known as uidoquinol and iodoquinol, is a quinoline derivative that can be used in the treatment of amoebiasis. The exact mechanism of action is unknown.

    Mixtures: Alcortin A, Alcortin A
  8. Drug

    Panitumumab

    go.drugbank.com/drugs/DB01269
    ApprovedInvestigational

    Panitumumab was granted FDA approval on 27 September 2006.[L17663] … Panitumumab (ABX-EGF) is a recombinant human IgG2 monoclonal antibody that binds specifically to the human epidermal growth factor receptor (EGFR). This drug is an antineoplastic agent.

  9. Drug

    Barucainide

    go.drugbank.com/drugs/DB19585
    Experimental

    Barucainide has a monoisotopic molecular weight of 354.23 Da. … Barucainide is a small molecule drug. The usage of the INN stem '-cain-' in the name indicates that Barucainide is a class I antiarrhythmic, procainamide and lidocaine derivative.

  10. Drug

    Eptazocine

    go.drugbank.com/drugs/DB19670
    Experimental

    Eptazocine has a monoisotopic molecular weight of 231.16 Da. … Eptazocine is a small molecule drug. The usage of the INN stem '-azocine' in the name indicates that Eptazocine is a narcotic antagonist/agonist related to 6,7-benzomorphan.